You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 11, November 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Biases in the Laboratory Diagnosis of Depression in Medical Practice

Martin F. Shapiro, MD; Anthony F. Lehman, MD; Sheldon Greenfield, MD

Arch Intern Med. 1983;143(11):2085-2088.


Abstract

• Several studies, conducted in psychiatric settings, have reported that the dexamethasone suppression test (ST) is useful in the diagnosis of endogenous depression. To determine whether the test has clinical utility in internal medicine practice, data were reviewed and reanalyzed from all studies that evaluated the dexamethasone ST in the diagnosis of depression. In these 11 studies, the mean positive predictive value reported for the test was 84%, reflecting high prevalence of disease (50%), sensitivity (43%), and specificity (92%) in those specialized populations studied. When estimates of the prevalence and severity of conditions associated with depressed mood seen in internal medicine were used, the sensitivity dropped to 30%, and the specificity to 85%. Assuming a prevalence of 20%, a figure based on available epidemiologic data, the predictive value for a positive test would be 33%, too low to have value in most clinical settings. Data from studies currently available do not support the use of dexamethasone ST in internal medicine practice. More generally, before any test is adopted in a general medical setting, it should be studied in that setting, or available data should be reanalyzed to correct for biases affecting prevalence, sensitivity, and specificity that may inflate the test's value.

(Arch Intern Med 1983;143:2085-2088)



Author Affiliations

From the Department of Medicine, University of California, Los Angeles (Drs Shapiro and Greenfield), and the Department of Psychiatry, University of Rochester (NY) (Dr Lehman). Dr Shapiro is a Henry J. Kaiser Family Foundation Faculty Scholar in general internal medicine.


Footnotes

Accepted for publication April 14, 1983.

Read in part before the national meeting of the American Federation for Clinical Research, Washington, DC, May 10, 1982.

Reprint requests to Division of General Internal Medicine and Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024 (Dr Shapiro).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Dexamethasone Suppression Test for Diagnosis and Prognosis in Psychiatry: Commentary and Review
Arana et al.
Arch Gen Psychiatry 1985;42:1193-1204.
ABSTRACT  

The Dexamethasone Suppression Test for the Detection, Diagnosis, and Management of Depression
ANN INTERN MED 1984;100:307-308.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.